drug
H-002
Phase 2updated 3mo agoby RedCloud Bio Inc
Phase 2community read0 votes
indications
indications
NSCLC
all catalysts(0)
nothing on the calendar yet
Trials studying H-002
- phase3A Comparative Study of Efficacy and Safety of RPH-002 and Erbitux® in Unresectable Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma
- phase1A Phase I Comparative Study of Pharmacokinetics, Safety, and Efficacy of RPH-002 and Erbitux® in Unresectable Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 13m ago
Found something off?
comments(0)
5-min edit window · permanent after that